Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin vs Glimepiride in T2DM on Metformin
NCT00968812Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of canagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Janssen Pharmaceutical. Started Sep 2009; status: completed.
02
Drugs
canagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00968812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00968812.